D040501Chemicals & DrugsD12.776.157.125.750.500.100D12.776.631.655.500.100D23.050.301.562.1008110.988233Calgranulin Aprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonPediatrics-RheumatologyMicrobiology30225949Hinze CH, Foell D, Johnson AL, Spalding SJ, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Mehta J, Ting TV, Verbsky JW, Eberhard AB, Huang B, Giannini EH, Lovell DJArthritis & rheumatology (Hoboken, N.J.)Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. Arthritis Rheumatol. 2019 03; 71(3):451-459.Arthritis Rheumatol2019-01-24T00:00:002019Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.1.382760.03120338research area of0.8441140.10036817subject area forShabaanaKhaderShabaana Khader41.7886000000000087.598699999999994229Khader, ShabaanaProfessor24047412Gopal R, Monin L, Torres D, Slight S, Mehra S, McKenna KC, Fallert Junecko BA, Reinhart TA, Kolls J, Báez-Saldaña R, Cruz-Lagunas A, Rodríguez-Reyna TS, Kumar NP, Tessier P, Roth J, Selman M, Becerril-Villanueva E, Baquera-Heredia J, Cumming B, Kasprowicz VO, Steyn AJ, Babu S, Kaushal D, Zúñiga J, Vogl T, Rangel-Moreno J, Khader SAAmerican journal of respiratory and critical care medicineS100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. Am J Respir Crit Care Med. 2013 Nov 01; 188(9):1137-46.Am J Respir Crit Care Med2013-11-01T00:00:002013S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis.34728150Mellett L, Khader SACytokine & growth factor reviewsS100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes. Cytokine Growth Factor Rev. 2022 02; 63:90-97.Cytokine Growth Factor Rev2021-10-17T00:00:002021S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes.32134742Scott NR, Swanson RV, Al-Hammadi N, Domingo-Gonzalez R, Rangel-Moreno J, Kriel BA, Bucsan AN, Das S, Ahmed M, Mehra S, Treerat P, Cruz-Lagunas A, Jimenez-Alvarez L, Muñoz-Torrico M, Bobadilla-Lozoya K, Vogl T, Walzl G, du Plessis N, Kaushal D, Scriba TJ, Zúñiga J, Khader SAThe Journal of clinical investigationS100A8/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis. J Clin Invest. 2020 06 01; 130(6):3098-3112.J Clin Invest2020-06-01T00:00:002020S100A8/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis.PathologyRadiologyUniversity of ChicagoLindaWagner-WeinerLinda Wagner-Weiner41.78927490000000-87.601250000000001321Wagner-Weiner, LindaClinical Associate ProfessorRobertSilversRobert Silvers41.78927490000000-87.601250000000001343Silvers, RobertClinical Assistant ProfessorMark W.Lingen22tnDKQbOfnamXNnYUHhvWD+6g==Mark W. Lingen41.78927490000000-87.60125000000000864Lingen, Mark W.ProfessorMelissaTesherMelissa Tesher41.78927490000000-87.60125000000000958Tesher, MelissaAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Clinical Associate ProfessorClinical Associate Professortrue1Clinical Assistant ProfessorClinical Assistant Professor26883112Khammanivong A, Sorenson BS, Ross KF, Dickerson EB, Hasina R, Lingen MW, Herzberg MCOncotargetInvolvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC. Oncotarget. 2016 Mar 22; 7(12):14029-47.Oncotarget2016-03-22T00:00:002016Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC.